Annamaria Lobifaro - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2021	2
2022	1
2024	0

Page 1

Medium-to-Long-Term Immunogenicity of BNT162b2 mRNA COVID-19 Vaccine: A Retrospective Cohort Study.

Bianchi FP, Stefanizzi P, Germinario CA, Migliore G, Vimercati L, Martinelli A, Lobifaro A, Diella G, Larocca AMV, Control Room Working Group, Tafuri S. Bianchi FP, et al. Vaccines (Basel). 2022 Mar 10;10(3):417. doi: 10.3390/vaccines10030417. Vaccines (Basel). 2022. PMID: 35335049 Free PMC article.

BNT162b2 mRNA COVID-19 Vaccine Effectiveness in the Prevention of SARS-CoV-2 Infection: A Preliminary Report.

Bianchi FP, Germinario CA, Migliore G, Vimercati L, Martinelli A, Lobifaro A, Tafuri S, Stefanizzi P; Control Room Working Group. Bianchi FP, et al. J Infect Dis. 2021 Aug 2;224(3):431-434. doi: 10.1093/infdis/jiab262. J Infect Dis. 2021. PMID: 34007998 Free PMC article.

BNT162b2 mRNA COVID-19 Vaccine Effectiveness in the Prevention of SARS-CoV-2 Infection and Symptomatic Disease in Five-Month Follow-Up: A Retrospective Cohort Study.

Bianchi FP, Tafuri S, Migliore G, Vimercati L, Martinelli A, Lobifaro A, Diella G, Stefanizzi P; Control Room Working Group. Bianchi FP, et al. Vaccines (Basel). 2021 Oct 7;9(10):1143. doi: 10.3390/vaccines9101143. Vaccines (Basel). 2021. PMID: 34696252 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

3 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

3 results

Results by year